Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6864 stock hub

TPEX/6864 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6864is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6864

In the news

Latest news · TPEX/6864

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-41.6

P25 -16.2P50 0.3P75 9.8

ROIC-26.4

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6864 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

TWD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 1.7B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006864002
Last refreshed	2026-05-10
Market cap	TWD 1.9B
Price	TWD 57.1
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/6864
Website	https://www.ams-bioteq.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4%
EV Earnings	-22.44x
EV/FCF	-23.06x
FCF yield	-3.89%
P/B ratio	7.86x
P/S ratio	3,046.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	23.53%
Gross Profit	TWD 144,000
Gross Profit Growth	-44.83%
Gross Profit Growth3 Y	-48.63%
Gross Profit Growth5 Y	25.1%
Net Income	TWD -74.5M
Net Income Growth Years	0%
Pretax Margin	-12,175.98%
ROA	-25.41
Roa5y	-16.61
ROCE	-32.2
ROE	-41.59
Roe5y	-24.09
ROIC	-26.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-40.62%
Cagr3y	15.03%
EPS Growth Years	0
Revenue Growth	-15.93x
Revenue Growth Q	-50.09x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-35.44x
Revenue Growth5 Y	47.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0
Assets	TWD 248.2M
Cash	TWD 194.1M
Current Assets	TWD 202.9M
Current Liabilities	TWD 10.7M
Debt	TWD 2.4M
Debt Equity	TWD 0.01
Debt FCF	TWD -0.03
Equity	TWD 237.3M
Interest Coverage	-2,389.9
Liabilities	TWD 10.9M
Long Term Assets	TWD 45.3M
Long Term Liabilities	TWD 194,000
Net Cash	TWD 191.7M
Net Cash By Market Cap	TWD 10.29
Net Cash Growth	88.35%
Net Debt Equity	TWD -0.81
Tangible Book Value	TWD 237.3M
Tangible Book Value Per Share	TWD 7.35
WACC	4.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	19.01
Inventory Turnover	0.35
Net Working Capital	TWD 256,000
Quick ratio	18.24
Working Capital	TWD 192.2M
Working Capital Turnover	TWD 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-40.6%
200-day SMA	75.99
3Y total return	52.22%
50-day SMA	60.1
50-day SMA vs 200-day SMA	50under200
All Time High	125.5
All Time High Change	-54.5%
All Time High Date	2025-03-18
All Time Low	20.95
All Time Low Change	172.55%
All Time Low Date	2022-11-07
ATR	2.16
Beta	-0.03
Beta1y	0.46
Beta2y	0.01
Ch YTD	-33.76
High	59.1
High52	98.3
High52 Date	2025-05-20
High52ch	-42.09%
Low	56.9
Low52	48
Low52 Date	2026-03-13
Low52ch	18.96%
Ma50ch	-4.99%
Price vs 200-day SMA	-24.86%
RSI	40.73
RSI Monthly	44.49
RSI Weekly	39.02
Sharpe ratio	-1.13x
Sortino ratio	-1.86
Total Return	-21.09%
Tr YTD	-33.76
Tr1m	-3.55%
Tr1w	-4.03%
Tr3m	-20.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -76.5M
Operating margin	-12,496.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,809,928%
Net Borrowing	-2,252,000
Shares Insiders	17.22%
Shares Out	32,534,750
Shares Qo Q	14.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -72.8M
Average Volume	46,958.65x
Bv Per Share	7.35
CAPEX	TWD -8.4M
Ch1m	-3.55
Ch1w	-4.03
Ch1y	-41.44
Ch3m	-20.25
Ch3y	48.51
Ch6m	-30.37
Change	-2.39%
Change From Open	-3.38
Close	58.5
Days Gap	1.03
Depreciation Amortization	10,816,000
Dollar Volume	2,145,418.3
Earnings Date	2026-03-30
EBIT	TWD -76.5M
EBITDA	TWD -65.7M
EPS	TWD -2.46
F Score	2
FCF	TWD -72.5M
FCF EV Yield	-4.34x
FCF Per Share	TWD -2.23
Financing CF	188,164,000
Fiscal Year End	December
Founded	2,018
Investing CF	-8,316,000
Is Primary Listing	1
Last Report Date	2024-12-31
Ma150	72.94
Ma150ch	-21.71%
Ma20	58.39
Ma20ch	-2.21%
Net CF	115,700,000
Open	59.1
Position In Range	9.09
Ppne	21,407,000
Price Date	2026-05-08
Ptbv Ratio	7.86
Relative Volume	0.79x
Revenue	612,000x
SBC By Revenue	53.27x
Share Based Comp	326,000
Tr6m	-29.37%
Volume	37,573
Z Score	52.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6864 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6864 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6864?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+17.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/6864 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.7

Neutral momentum band

Price vs 200-day MA

-24.9%

50/200-day relationship not available

Beta (5Y)

-0.03

Less volatile than the market

Sharpe ratio

-1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6864

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6864 stock rating?

tpex/6864 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6864 analysis?

The full report lives at /stocks/tpex/6864/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6864?

The latest report frames tpex/6864 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6864 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.